Literature DB >> 27195240

New Insight into Effects of β-Blockers on Arterial Functions.

Kazuo Eguchi1.   

Abstract

The effects of β-blockers on arterial properties are not well investigated. In our recent study, we compared the effects of the two β-blockers celiprolol and bisoprolol on blood pressure, baroreflex sensitivity (BRS), flow-mediated vasodilatation, and vascular stiffness. We found that bisoprolol achieved a greater reduction in the pulse rate and improved BRS and vascular stiffness, whereas celiprolol reduced the central blood pressure level. In this review, the mechanisms of different types of β-blockers and their effects on arteries are discussed, and the appropriate use of β-blockers in hypertensive subjects will be proposed.

Entities:  

Keywords:  Ambulatory blood pressure; Bisoprolol; Celiprolol; Central blood pressure; Flow-mediated vasodilation; Home blood pressure; Pulse wave velocity; Urinary albumin excretion ratio

Year:  2016        PMID: 27195240      PMCID: PMC4865072          DOI: 10.1159/000443615

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  24 in total

1.  Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

Authors:  P Boutouyrie; C Bussy; D Hayoz; J Hengstler; N Dartois; B Laloux; H Brunner; S Laurent
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

Review 2.  Expert consensus document on beta-adrenergic receptor blockers.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

3.  Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.

Authors:  R G Asmar; J C Kerihuel; X J Girerd; M E Safar
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

4.  Mental stress induces transient endothelial dysfunction in humans.

Authors:  L Ghiadoni; A E Donald; M Cropley; M J Mullen; G Oakley; M Taylor; G O'Connor; J Betteridge; N Klein; A Steptoe; J E Deanfield
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

5.  Different effect of antihypertensive drugs on conduit artery endothelial function.

Authors:  Lorenzo Ghiadoni; Armando Magagna; Daniele Versari; Isabella Kardasz; Yale Huang; Stefano Taddei; Antonio Salvetti
Journal:  Hypertension       Date:  2003-04-28       Impact factor: 10.190

6.  Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2015-01-10       Impact factor: 2.689

7.  Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.

Authors:  Leszek Kalinowski; Lawrence W Dobrucki; Miroslawa Szczepanska-Konkel; Maciej Jankowski; Ludmila Martyniec; Stefan Angielski; Tadeusz Malinski
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.

Authors:  Isla S Mackenzie; Carmel M McEniery; Zahid Dhakam; Morris J Brown; John R Cockcroft; Ian B Wilkinson
Journal:  Hypertension       Date:  2009-06-01       Impact factor: 10.190

9.  Prevention of ventricular fibrillation requires central beta-adrenoceptor blockade in rabbits.

Authors:  Bengt Ablad; Thorvald Bjurö; Jan-Arne Björkman; Therese Edström
Journal:  Scand Cardiovasc J       Date:  2007-08       Impact factor: 1.589

10.  Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.

Authors:  Roberto Nerla; Antonino Di Franco; Maria Milo; Dario Pitocco; Francesco Zaccardi; Pierpaolo Tarzia; Filippo Maria Sarullo; Angelo Villano; Giulio Russo; Alessandra Stazi; Giovanni Ghirlanda; Gaetano Antonio Lanza; Filippo Crea
Journal:  Heart       Date:  2012-10-19       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.